Literature DB >> 12548732

DiGeorge/velocardiofacial syndrome: FISH studies of chromosomes 22q11 and 10p14, and clinical reports on the proximal 22q11 deletion.

Oliver Bartsch1, Michaela Nemecková, Eduard Kocárek, Annett Wagner, Alena Puchmajerová, Maja Poppe, Katrin Ounap, Petr Goetz.   

Abstract

DiGeorge anomaly/velocardiofacial syndrome (DG/VCFS) occurs with different deletion intervals on chromosomes 22q11, while the DiGeorge anomaly (with other findings) is seen in patients with deletions of 10p14. The clinical outcome with the common 22q11 deletion (90% of cases) is well known, but the outcome with the less frequent deletion types has not been well documented. Using cytogenetic and fluorescence in situ hybridization (FISH) analysis we studied a series of 295 patients with suspected DG/VCFS. We identified 58 subjects with a 22q11 deletion, and none with a 10p deletion. Fifty-two subjects had the common deletion, five had the proximal deletion, and one had an atypical proximal deletion due to a 1;22 translocation. We report clinical data of four subjects with the proximal 22q11 microdeletion, and of one patient with the atypical proximal deletion. The anomalies observed with the proximal 22q11 microdeletion fell within the DG/VCFS spectrum. Two females, 6 and 25 years old, had normal mental development. Normal development has been reported with the common 22q11 deletion, but only in a minority of cases. This study may indicate a better intellectual and/or behavioral outcome with the proximal vs. the common 22q11 deletion, rather than a chance finding. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12548732     DOI: 10.1002/ajmg.a.10914

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  11 in total

1.  Genomic imbalances in mental retardation.

Authors:  M Kriek; S J White; M C Bouma; H G Dauwerse; K B M Hansson; J V Nijhuis; B Bakker; G-J B van Ommen; J T den Dunnen; M H Breuning
Journal:  J Med Genet       Date:  2004-04       Impact factor: 6.318

2.  Molecular characterization of deletion breakpoints in adults with 22q11 deletion syndrome.

Authors:  Rosanna Weksberg; Andrea C Stachon; Jeremy A Squire; Laura Moldovan; Jane Bayani; Stephen Meyn; Eva Chow; Anne S Bassett
Journal:  Hum Genet       Date:  2006-10-07       Impact factor: 4.132

3.  Unique Combination of 22q11 and 14qter Microdeletion Syndromes Detected Using Oligonucleotide Array-CGH.

Authors:  E Zrnová; V Vranová; J Soukalová; I Slámová; M Vilémová; R Gaillyová; P Kuglík
Journal:  Mol Syndromol       Date:  2012-01-26

4.  Defining new guidelines for screening the 22q11.2 deletion based on a clinical and dysmorphologic evaluation of 194 individuals and review of the literature.

Authors:  Fabíola P Monteiro; Társis P Vieira; Ilária C Sgardioli; Miriam C Molck; Ana Paula Damiano; Josiane Souza; Isabella L Monlleó; Marshall I B Fontes; Agnes C Fett-Conte; Têmis M Félix; Gabriela F Leal; Erlane M Ribeiro; Claudio E M Banzato; Clarissa de R Dantas; Iscia Lopes-Cendes; Vera Lúcia Gil-da-Silva-Lopes
Journal:  Eur J Pediatr       Date:  2013-02-26       Impact factor: 3.183

5.  CHARGE (coloboma, heart defect, atresia choanae, retarded growth and development, genital hypoplasia, ear anomalies/deafness) syndrome and chromosome 22q11.2 deletion syndrome: a comparison of immunologic and nonimmunologic phenotypic features.

Authors:  Soma Jyonouchi; Donna M McDonald-McGinn; Sherri Bale; Elaine H Zackai; Kathleen E Sullivan
Journal:  Pediatrics       Date:  2009-05       Impact factor: 7.124

6.  22q11.2 Deletion Syndrome: Laboratory Diagnosis and TBX1 and FGF8 Mutation Screening.

Authors:  Ilária C Sgardioli; Társis P Vieira; Milena Simioni; Fabíola P Monteiro; Vera L Gil-da-Silva-Lopes
Journal:  J Pediatr Genet       Date:  2015-03

7.  C1-2 vertebral anomalies in 22q11.2 microdeletion syndrome.

Authors:  Osnat Konen; Derek Armstrong; Howard Clarke; Nancy Padfield; Rosanna Weksberg; Susan Blaser
Journal:  Pediatr Radiol       Date:  2008-05-31

8.  Genetics and public health: the experience of a reference center for diagnosis of 22q11.2 deletion in Brazil and suggestions for implementing genetic testing.

Authors:  Társis Paiva Vieira; Ilária Cristina Sgardioli; Vera Lúcia Gil-da-Silva-Lopes
Journal:  J Community Genet       Date:  2012-10-21

Review 9.  Approach to the patient with recurrent infections.

Authors:  Mark Ballow
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 10.817

10.  Chordin is a modifier of tbx1 for the craniofacial malformations of 22q11 deletion syndrome phenotypes in mouse.

Authors:  Murim Choi; John Klingensmith
Journal:  PLoS Genet       Date:  2009-02-27       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.